Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion‐451840 in an induced blood stage malaria study in healthy subjects

Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion‐451840 in an induced blood stage malaria study in healthy subjects

Bibliographic Details
Main Authors:	Krause, Andreas, Dingemanse, Jasper, Mathis, Alexandre, Marquart, Louise, Möhrle, Jörg J., McCarthy, James S.
Format:	Online
Language:	English
Published:	John Wiley and Sons Inc. 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972157/

Similar Items

Absence of Pharmacokinetic and Pharmacodynamic Interactions between Almorexant and Warfarin in Healthy Subjects
by: Dingemanse, Jasper, et al.
Published: (2013)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand
by: Tarning, J, et al.
Published: (2014)

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
by: White, Nicholas J.
Published: (2013)

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling
by: Le Bihan, Amélie, et al.
Published: (2016)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
by: Sidharta, P. N., et al.
Published: (2015)

Pharmacodynamic studies of antimalarial drugs in a murine malaria model
by: Moore, Brioni R.
Published: (2011)

Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin
by: Gibbons, Peter, et al.
Published: (2007)

Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model
by: Moore, Brioni, et al.
Published: (2008)

Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
by: McCarthy, James S., et al.
Published: (2016)

Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
by: Togawa, Michinori, et al.
Published: (2016)

Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate
by: Wein, S, et al.
Published: (2012)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Geisser, Peter, et al.
Published: (2011)

Differences in the pharmacokinetics of currently approved antimalarial drugs in uncomplicated malaria patients compared to healthy subjects
by: Jain, Jay Prakash, et al.
Published: (2012)

Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs
by: Kay, Katherine, et al.
Published: (2013)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
by: Stein, Daniel S, et al.
Published: (2014)

Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance
by: Marquart, Louise, et al.
Published: (2012)

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
by: Cui, Yimin, et al.
Published: (2013)

Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
by: Loprete, Luca, et al.
Published: (2016)

Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
by: Kim, Choon Ok, et al.
Published: (2016)

Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects
by: Chen, Xia, et al.
Published: (2015)

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung, Jin Ah, et al.
Published: (2015)

Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects
by: Boyce, M, et al.
Published: (2016)

Pharmacokinetics, Pharmacodynamics and Allometric Scaling of Chloroquine in a Murine Malaria Model
by: Moore, Brioni, et al.
Published: (2011)

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults
by: Byakika-Kibwika, Pauline, et al.
Published: (2012)

Pharmacokinetics and allometric scaling of antimalarial drugs
by: Senarathna, Senarathna Mudiyanselage Dona Kalyani Ganga
Published: (2015)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
by: Lees, Peter, et al.
Published: (2003)

Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
by: Finley, Stacey D, et al.
Published: (2011)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
by: Johnston, AJ, et al.
Published: (2003)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
by: Shin, Jai Moo, et al.
Published: (2013)

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
by: Mueck, Wolfgang, et al.
Published: (2013)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
by: de Vries Schultink, Aurelia H. M., et al.
Published: (2015)

A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs
by: McCarthy, James S., et al.
Published: (2011)

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
by: McCarthy, James S., et al.
Published: (2016)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
by: Sakurai, Yuuichi, et al.
Published: (2015)

The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins
by: Friedrich, S, et al.
Published: (2014)

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design
by: Reddy, Micaela B., et al.
Published: (2015)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
by: Phyo, Aung Pyae, et al.
Published: (2016)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
by: Bouazza, Naïm, et al.
Published: (2011)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
by: Lozano, Roberto, et al.
Published: (2013)